Literature DB >> 1607637

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

B J Kerns1, P A Jordan, M B Moore, P A Humphrey, A Berchuck, M F Kohler, R C Bast, J D Iglehart, J R Marks.   

Abstract

Mutation and overexpression of the p53 gene have been noted in a wide range of human cancers and are thought to play a role in malignant transformation. Previously, immunohistochemical detection of p53 has been possible only in fresh-frozen tissues. We examined p53 expression in paraffin-embedded tissues from 50 epithelial ovarian cancers and 25 primary breast cancers with a modified immunohistochemical (IHC) technique developed in this laboratory, using monoclonal antibody (MAb) PAb1801. The 75 cases were selected from a group of patients in whom the expression levels had already been assessed in a fresh-tissue IHC assay. An identical staining reactivity was observed in both formalin-fixed, paraffin-embedded tissue and fresh-frozen tissue in 48 of 50 (96%) epithelial ovarian cancers and in 23 of 25 (92%) primary breast cancers. Immunodetection of p53 in paraffin-embedded tissue blocks will be a useful alternative to the standard fresh-tissue assay and can accurately reflect the level of p53 expression in human tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607637     DOI: 10.1177/40.7.1607637

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

2.  Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis.

Authors:  Hiroshi Y Yamada; Yixin Yao; Xiaoxing Wang; Yuting Zhang; Ying Huang; Wei Dai; Chinthalapally V Rao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

3.  Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.

Authors:  R F Caduff; C M Johnston; S M Svoboda-Newman; E L Poy; S D Merajver; T S Frank
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Authors:  R P Zweemer; P A Shaw; R M Verheijen; A Ryan; A Berchuck; B A Ponder; H Risch; J R McLaughlin; S A Narod; F H Menko; P Kenemans; I J Jacobs
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

5.  p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation.

Authors:  Achille Pich; Laura Godio; Laura Davico Bonino
Journal:  Mol Clin Oncol       Date:  2017-04-21

6.  Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.

Authors:  W Hilbe; S Dirnhofer; F Oberwasserlechner; W Eisterer; K Ammann; T Schmid; G Hilbe; J Thaler; E Wöll
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

7.  Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.

Authors:  E Latres; M Drobnjak; D Pollack; M R Oliva; M Ramos; M Karpeh; J M Woodruff; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases.

Authors:  G MacGrogan; F Bonichon; I de Mascarel; M Trojani; M Durand; A Avril; J M Coindre
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

9.  P53 protein in 204 patients with primary breast carcinoma--immunohistochemical detection and clinical value as a prognostic factor.

Authors:  U J Göhring; A Scharl; C Heckel; A Ahr; G Crombach
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

10.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

Authors:  S Bosari; G Viale; M Roncalli; D Graziani; G Borsani; A K Lee; G Coggi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.